DGX peer analysis
Quest Diagnostics (DGX) against its competitors: price, today's move, 1-year return and market value side by side.
DGX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| GH Guardant Health | $172.67 | -3.43% | 86.85% | $23.99B |
| GRAL GRAIL | $134.98 | -5.89% | 58.41% | – |
| ILMN Illumina | $228.08 | -3.35% | 130.36% | $35.63B |
| LH Labcorp | $356.77 | -1.28% | 41.39% | $29.34B |
| NTRA Natera | $387.31 | -6.51% | 100.45% | $59.72B |
| QGEN QIAGEN | $50.38 | 0.32% | 8.74% | $10.37B |
| RDNT RadNet | $74.15 | 0.90% | -2.56% | $5.78B |
| RVTY Revvity | $153.22 | -2.41% | 68.34% | – |
| DGX Quest Diagnostics | $250.00 | -0.72% | 42.25% | $27.79B |
- DGX's peers: GH (Guardant Health), GRAL (GRAIL), ILMN (Illumina), LH (Labcorp), NTRA (Natera), QGEN (QIAGEN), RDNT (RadNet), RVTY (Revvity).
Updated 2026-11-03 02:03 UTC